or
Bookmark and Share
Substituted dialkanolamines, sulfur analogs and condensed 1,4-oxazine derivatives thereof in viral disease treatment
   
Document Number
US Patent 4803200
Issued Date
February 7, 1989
Link
Map
Abstract
Substituted dialkanolamines, oxazine and sulfur analogs thereof, useful in treating shipping fever syndrome in mammals are disclosed having the formula: ##STR1## wherein: Ar is ##STR2## Z is oxygen or sulfur; R is selected from hydrogen, loweralkyl or ##STR3## R.sup.1 R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are selected from hydrogen or loweralkyl; and ##STR4## when taken together may form a lowercycloalkyl ring or R.sup.5 with --ZR.sup.2 when taken together may form a 5-membered saturated oxygen or sulfur containing heterocyclic ring; X is selected from hydrogen, halo, loweralkoxy, loweralkyl, trifluoromethyl or dimethylamino and when X is more than 1, it may be the same radical or different; y is 0, 1 or 2; n is one, or zero and when n is 1, the stereoisomers thereof and when n is zero the dotted line becomes an oxygen-carbon bond forming an oxazine ring and the pharmaceutically acceptable acid addition salts thereof.
Drawing
Substituted dialkanolamines, sulfur analogs and condensed 1,4-oxazine derivatives thereof in viral disease treatment - US Patent 4803200 Drawing
Drawing from US Patent 4803200
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
36
Comments:
no comments yet
Owner
Published
February 7, 1989
Application Number
07/103,938
Filed
October 2, 1987
US Classification
514/231.2   514/471 514/654
Int'l Classification
C07D   307/00   (20060101)   C07D   307/14   (20060101)   C07D   265/00   (20060101)   C07D   265/30   (20060101)  
Examiner
USPTO Field of Search
514/231.2   514/471   514/654  
Related Patents
5171753 - Derivatives of 2-amino-1-phenylethanol having antiulcer activity - Owned by A. H. Robins Company, Incorporated (Richmond, VA)

Derivatives of 2-amino-1-phenylethanol were prepared from substituted amines and benzoin, stilbene oxide or styrene oxide to give compounds of Formula: ##STR1## where R is H or (un)substituted phenyl and C is a linking group or terminal group. The compounds of this invention can inhibit ulceration in in-vivo studies in rats.

5648347 - Arylmorpholine, preparation and use - Owned by Glaxo Wellcome Inc. (Research Triangle Park, NC)

A method for the treatment of depression in a human being, the method comprising administering to the human being an antidepressant effective amount of a compound of the following formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein R and R.sup.1 are independently hydrogen or fluorine.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us